Moorestown, NJ, United States of America

Yuri Nikolyukin

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Portascience Incorporated. Active years: 2003-2004.


% Patents Active = 50.0


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Yuri Nikolyukin

Introduction

Yuri Nikolyukin is a notable inventor based in Moorestown, NJ (US). He has made significant contributions to the field of medical diagnostics, holding 2 patents that showcase his innovative approaches to health measurement technologies.

Latest Patents

One of his latest patents is a method and apparatus for measuring white blood cell count. This method involves capturing white blood cells from a fluid sample using a retainer, followed by the removal of red blood cells and other interfering substances with a wash solution. The results are read through a color reaction where an ester present on the white blood cells cleaves a chromogenic substrate, producing a water-insoluble dye. Another significant patent is for a method for the quantitative determination of glycated hemoglobin. This system separates glycated hemoglobin from non-glycated hemoglobin and allows for a one-read quantitative determination of glycated hemoglobin and % HbA without needing an additional measurement of total hemoglobin.

Career Highlights

Yuri Nikolyukin is currently associated with Portascience Incorporated, where he continues to develop innovative solutions in medical diagnostics. His work has the potential to improve the accuracy and efficiency of blood analysis, which is crucial for patient care.

Collaborations

Yuri collaborates with talented individuals such as Wai Law and Inna Nikolyukin, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Yuri Nikolyukin's contributions to medical diagnostics through his patents reflect his commitment to advancing healthcare technology. His innovative methods for measuring white blood cell count and glycated hemoglobin are significant steps forward in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…